- Home
- APLS vs XXI Comparison
APLS vs XXI Comparison
Compare APLS & XXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$17.28
Company Overview
Basic Information| Metric | APLS | XXI |
|---|---|---|
| Founded | 2009 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.4B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | APLS | XXI |
|---|---|---|
| Price | $17.28 | $7.04 |
| Analyst Decision | Buy | |
| Analyst Count | 21 | 0 |
| Target Price | ★ $31.65 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 998.5K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 112.50 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $1,003,782,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.21 | N/A |
| P/E Ratio | $86.38 | ★ N/A |
| Revenue Growth | ★ 28.46 | N/A |
| 52 Week Low | $16.10 | $5.61 |
| 52 Week High | $30.48 | $11.49 |
Technical Indicators
Market Signals| Indicator | APLS | XXI |
|---|---|---|
| Relative Strength Index (RSI) | 27.60 | 53.02 |
| Support Level | $17.16 | $5.68 |
| Resistance Level | $20.42 | $9.97 |
| Average True Range (ATR) | 0.71 | 0.37 |
| MACD | -0.15 | 0.09 |
| Stochastic Oscillator | 12.23 | 75.28 |
Price Performance
Historical Comparison APLS
XXI
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About XXI Twenty One Capital Inc. Class A Common Stock
Twenty One Capital Inc has no operation history.